MiNK Therapeutics (Nasdaq: INKT) today announced that new translational data supporting the role of invariant natural killer T (iNKT) cells in idiopathic pulmonary fibrosis (IPF) were presented at the ...

Opportunistic infections can contribute to antimicrobial resistance making these infections more severe than would occur otherwise. Some uninvolved pathogens that cause these infections possess ...